GlassScriptPhysician profile
Devin Stewart
NPI 1609671791
$718.07
in general payments reported to CMS, 2019-2025
16 companies · $718 in 2025
The $718 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $147.58 | 2025 | Ibsrela |
| Lilly USA, LLC | $81.76 | 2025 | Mounjaro, Zepbound |
| Amgen INC. | $81.32 | 2025 | Otezla, Repatha, Krystexxa |
| Sumitomo Pharma America, INC. | $63.08 | 2025 | Gemtesa |
| Novo Nordisk INC | $59.46 | 2025 | Wegovy, Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $57.69 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $47.12 | 2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $29.71 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $29.49 | 2025 | Farxiga |
| Teva Pharmaceuticals USA, INC. | $22.13 | 2025 | Austedo Xr |
| Corcept Therapeutics | $22.07 | 2025 | Korlym |
| Hologic Sales and Service, LLC | $17.26 | 2025 | Aptima, Thinprep 2000 Processor |
| Xeris Pharmaceuticals, INC. | $16.39 | 2025 | Gvoke Hypopen |
| Alkermes, INC. | $16.32 | 2025 | Aristada, Lybalvi |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $11.69 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.